Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 2
1975 1
1976 1
1978 2
1979 1
1980 4
1981 9
1982 6
1984 7
1985 5
1986 7
1987 4
1988 3
1989 4
1990 5
1991 8
1992 4
1993 6
1994 13
1995 4
1996 11
1997 6
1998 6
1999 11
2000 10
2001 7
2002 9
2003 5
2004 7
2005 1
2006 7
2007 5
2008 8
2009 6
2010 8
2011 10
2012 10
2013 7
2014 8
2015 3
2016 11
2017 8
2018 2
2019 3
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

261 results
Results by year
Filters applied: . Clear all
Page 1
Tolerance and exhaustion: defining mechanisms of T cell dysfunction.
Schietinger A, Greenberg PD. Schietinger A, et al. Among authors: greenberg pd. Trends Immunol. 2014 Feb;35(2):51-60. doi: 10.1016/ Epub 2013 Nov 6. Trends Immunol. 2014. PMID: 24210163 Free PMC article. Review.
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.
Anderson KG, Stromnes IM, Greenberg PD. Anderson KG, et al. Among authors: greenberg pd. Cancer Cell. 2017 Mar 13;31(3):311-325. doi: 10.1016/j.ccell.2017.02.008. Cancer Cell. 2017. PMID: 28292435 Free PMC article. Review.
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant.
Chapuis AG, Egan DN, Bar M, Schmitt TM, McAfee MS, Paulson KG, Voillet V, Gottardo R, Ragnarsson GB, Bleakley M, Yeung CC, Muhlhauser P, Nguyen HN, Kropp LA, Castelli L, Wagener F, Hunter D, Lindberg M, Cohen K, Seese A, McElrath MJ, Duerkopp N, Gooley TA, Greenberg PD. Chapuis AG, et al. Among authors: greenberg pd. Nat Med. 2019 Jul;25(7):1064-1072. doi: 10.1038/s41591-019-0472-9. Epub 2019 Jun 24. Nat Med. 2019. PMID: 31235963 Free PMC article.
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.
Paulson KG, Voillet V, McAfee MS, Hunter DS, Wagener FD, Perdicchio M, Valente WJ, Koelle SJ, Church CD, Vandeven N, Thomas H, Colunga AG, Iyer JG, Yee C, Kulikauskas R, Koelle DM, Pierce RH, Bielas JH, Greenberg PD, Bhatia S, Gottardo R, Nghiem P, Chapuis AG. Paulson KG, et al. Among authors: greenberg pd. Nat Commun. 2018 Sep 24;9(1):3868. doi: 10.1038/s41467-018-06300-3. Nat Commun. 2018. PMID: 30250229 Free PMC article.
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.
Schietinger A, Philip M, Krisnawan VE, Chiu EY, Delrow JJ, Basom RS, Lauer P, Brockstedt DG, Knoblaugh SE, Hämmerling GJ, Schell TD, Garbi N, Greenberg PD. Schietinger A, et al. Among authors: greenberg pd. Immunity. 2016 Aug 16;45(2):389-401. doi: 10.1016/j.immuni.2016.07.011. Epub 2016 Aug 9. Immunity. 2016. PMID: 27521269 Free PMC article.
Retraction. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death.
Brodie SJ, Patterson BK, Lewinsohn DA, Diem K, Spach D, Greenberg PD, Riddell SR, Corey L. Brodie SJ, et al. Among authors: greenberg pd. J Clin Invest. 2010 Sep;120(9):3401. doi: 10.1172/jci8707r1. J Clin Invest. 2010. PMID: 20830824 Free PMC article. No abstract available.
T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma.
Stromnes IM, Hulbert A, Pierce RH, Greenberg PD, Hingorani SR. Stromnes IM, et al. Among authors: greenberg pd. Cancer Immunol Res. 2017 Nov;5(11):978-991. doi: 10.1158/2326-6066.CIR-16-0322. Epub 2017 Oct 24. Cancer Immunol Res. 2017. PMID: 29066497 Free PMC article.
Engineered Adoptive T-cell Therapy Prolongs Survival in a Preclinical Model of Advanced-Stage Ovarian Cancer.
Anderson KG, Voillet V, Bates BM, Chiu EY, Burnett MG, Garcia NM, Oda SK, Morse CB, Stromnes IM, Drescher CW, Gottardo R, Greenberg PD. Anderson KG, et al. Among authors: greenberg pd. Cancer Immunol Res. 2019 Sep;7(9):1412-1425. doi: 10.1158/2326-6066.CIR-19-0258. Epub 2019 Jul 23. Cancer Immunol Res. 2019. PMID: 31337659 Free PMC article.
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
Su Y, Chen D, Yuan D, Lausted C, Choi J, Dai CL, Voillet V, Duvvuri VR, Scherler K, Troisch P, Baloni P, Qin G, Smith B, Kornilov SA, Rostomily C, Xu A, Li J, Dong S, Rothchild A, Zhou J, Murray K, Edmark R, Hong S, Heath JE, Earls J, Zhang R, Xie J, Li S, Roper R, Jones L, Zhou Y, Rowen L, Liu R, Mackay S, O'Mahony DS, Dale CR, Wallick JA, Algren HA, Zager MA; ISB-Swedish COVID19 Biobanking Unit, Wei W, Price ND, Huang S, Subramanian N, Wang K, Magis AT, Hadlock JJ, Hood L, Aderem A, Bluestone JA, Lanier LL, Greenberg PD, Gottardo R, Davis MM, Goldman JD, Heath JR. Su Y, et al. Among authors: greenberg pd. Cell. 2020 Oct 28:S0092-8674(20)31444-6. doi: 10.1016/j.cell.2020.10.037. Online ahead of print. Cell. 2020. PMID: 33171100 Free PMC article.
Fresh Beginnings.
Greenberg PD, Schreiber RD, Miller LJ. Greenberg PD, et al. Cancer Immunol Res. 2016 Jan;4(1):1-2. doi: 10.1158/2326-6066.CIR-15-0304. Cancer Immunol Res. 2016. PMID: 26729616 Free article. No abstract available.
261 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page